Please login to the form below

Not currently logged in
Email:
Password:

Vaxzevria

This page shows the latest Vaxzevria news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster

AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster

Vaxzevria, following a primary vaccine schedule of either Vaxzevria or an mRNA COVID-19 vaccine. ... Vaxzevria is known as a ‘viral vector’ vaccine, which uses a form of a virus that cannot cause disease to create the vaccine.

Latest news

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....